Navigation Links
Screening For Prostate Cancer in men over 75 Questioned

The prostate specific antigen test is a convenient and relatively inexpensive way for early detection of prostate cancer. While efficacy of PSA is controversial in younger men, doctors say there is a general consensus that the test //should not be given to men over 75. Despite this, a new study finds many physicians are suggesting and doing a PSA test on older men.

The decision to not screen older men with a PSA test is because the life expectancy without the test is nearly identical to men who have the test and undergo therapy for prostate cancer. Researchers reviewed information from a previous study to see who was initiating the idea and if physicians are discussing the risks and benefits of a PSA screening with patients before testing.

The study included information from 7,889 men who participated in a previous survey. Researchers report 32.5 percent of the men 75 years or older said they had a PSA screening during the last year. Among the men who had the test, 88.4 percent say their doctor suggested the screening and 66.5 percent reported having a discussion about the advantages and disadvantages of the test with their doctor before the screening was done.

Researchers say it is somewhat surprising so many physicians would suggest a screening in an elderly patient and they also say that the Ultimate, decision regarding the appropriateness of PSA screening in elderly men and the allocation of health care resources will have to be made by patients, physicians, and society working together. They say information about how patients and physicians interpret medical data on the PSA screening is critical to understanding the risks and benefits of this test in elderly men.

Page: 1

Related medicine news :

1. Screening device for ovarian cancer
2. Screening bypasses radical breast surgery
3. Screening of Lazy Eye
4. Screening Cost-Effective for Lung Cancer
5. Screening Newborns Questioned
6. Ultrasound Screening Could Improve The Outcome Of Critically ill Patients
7. The Effectiveness Of Screening Tests Questioned
8. Screening Test For Early Diagnosis Of Colorectal Cancer
9. The Importance Of Skin Cancer Screening
10. Ovarian Cancer Screening Questioned
11. Early Screening Required for Glaucoma
Post Your Comments:

(Date:10/13/2017)... ... ... On The Brink”: the Christian history of the United States and the loss of ... William Nowers. Captain Nowers and his wife, Millie, have six children, ten grandchildren, ... Navy. Following his career as a naval aviator and carrier pilot, he spent ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... treating sleep apnea using cutting-edge Oventus O2Vent technology. As many as ... disorder characterized by frequent cessation in breathing. Oral appliances can offer significant relief ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... meet the demand of today’s consumer and regulatory authorities worldwide. From Children’s to ... and tested to meet the highest standard. , These products are also: ...
(Date:10/12/2017)... ... October 12, 2017 , ... The American College of Medical Informatics (ACMI) will ... during the Opening Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual ... F. Collen, a pioneer in the field of medical informatics, this prestigious award is ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the technology: , ... to enable prevention of a major side effect of chemotherapy in children. Cisplatin ... patients. For cisplatin, hearing loss is FDA listed on-label as a dose limiting ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... NEW YORK , Sept. 27, 2017  DarioHealth Corp. ... big data solutions, today announced that its MyDario product is expected to ... TV listings for when The Dr. Oz Show airs in your area: ... The nine-time Emmy award-winning, ... ...
(Date:9/23/2017)... Pa. , Sept. 22, 2017 Janssen ... a complete response letter from the U.S. Food and ... seeking approval of sirukumab for the treatment of moderately ... letter indicates additional clinical data are needed to further ... moderately to severely active RA. ...
(Date:9/19/2017)... , Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical device company developing ... of targeted tissues, announced three leadership team developments today:   ... ... ... Veteran medical device executive Josh Stopek ...
Breaking Medicine Technology: